Item 8.01 Other Events.

On October 26, 2022, TELA Bio, Inc. (the "Company") issued a press release announcing the publication of the Company's 24-month analysis from the BRAVO study in the Annals of Medicine and Surgery. A copy of this press release is filed as Exhibit 99.1 hereto and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits

The following exhibits are being furnished herewith:





Exhibit No.   Document
  99.1          Press Release of TELA Bio, Inc., dated October 26, 2022.
104           Cover Page Interactive Data File (embedded within the Inline XBRL document).

© Edgar Online, source Glimpses